Osimertinib for maintenance treatment of EGFR mutation-positive locally advanced unresectable non-small-cell lung cancer after platinum-based chemoradiation [ID6223]

  • In development
  • GID-TA11232
  • Expected publication date: 

26769-TSID_10460-Osimertinib-for-Non-Small-Cell-Lung-Cancer-V1.0-NOV2022-NON-CONF.pdf (nihr.ac.uk)